Brief: Cullinan Therapeutics Provides Corporate Update And Reports Q3 2024 Financial Results
Nov 7 (Reuters) - Cullinan Therapeutics Inc CGEM.O :
* CULLINAN THERAPEUTICS PROVIDES CORPORATE UPDATE AND
REPORTS
THIRD QUARTER 2024 FINANCIAL RESULTS
* CULLINAN THERAPEUTICS QTRLY SHARE LOSS $0.69
* Q3 EARNINGS PER SHARE VIEW $-0.81 -- LSEG IBES DATA
Source text: ID:nGNX9SCVPp
Further company coverage: CGEM.O
((Reuters.Briefs@thomsonreuters.com;))